Walking Intervention for Post-Amputation Care
(DASH Trial)
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Walking Intervention for Post-Amputation Care is an effective treatment?
The available research does not provide specific data on the effectiveness of Walking Intervention for Post-Amputation Care. Instead, it focuses on other behavior change interventions for different conditions, such as diabetes and chronic illnesses. These studies highlight the importance of behavior change and self-management in improving health outcomes, but they do not directly address the effectiveness of walking interventions for post-amputation care.12345
What safety data exists for walking interventions in post-amputation care?
The provided research does not directly address the safety data for walking interventions in post-amputation care. However, it highlights the effectiveness of various interventions, such as biofeedback systems and gait training, in improving physical activity and gait rehabilitation for lower limb amputees. These studies suggest that interventions like overground and treadmill-based gait training, as well as lifestyle interventions, can improve physical and psychosocial functioning. While safety is not explicitly discussed, the effectiveness and focus on improving function imply a level of safety in these interventions. More specific safety data would require further investigation into individual studies or trials.678910
Is the Walking Biobehavioral Intervention a promising treatment for people who have had a leg amputation?
What is the purpose of this trial?
The purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.
Research Team
Cory Christiansen, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for adults aged 50-85 who've had a lower-limb amputation within the last year due to diabetes or peripheral artery disease. They should aim to walk using a prosthesis and not be undergoing active cancer treatment, have had trauma or cancer-related limb loss, recent stroke, cognitive challenges, or any condition making it unsafe to participate as judged by the study leader.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Conventional Prosthetic Rehabilitation
Participants undergo conventional prosthetic rehabilitation as part of the intervention
Biobehavioral Intervention
Participants receive biobehavioral training integrated into conventional outpatient training
Follow-up
Participants are monitored for maintenance of physical activity and other outcomes
Treatment Details
Interventions
- Attention Control
- Walking Biobehavioral Intervention
Walking Biobehavioral Intervention is already approved in United Kingdom for the following indications:
- Improving physical activity after dysvascular lower limb amputation
- Managing intermittent claudication in peripheral artery disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator